B2V536 AF NFT

Protein adenylyltransferase SelO

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihqbuz25f3nwzgwylptz7y74b6wex62hoapxrmqfnzfwap43su4zu/metadata.json
IPFS of structure file: 
bafybeifamovteocbqsgaqtdlxwtod2avcdixizedfd5vekbwh6qmn5upwq/AF-B2V536-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x76FE725d33d5838c54501068f07a12aAb661539b
First NFT owner address (bech32): 
genesis1wml8yhfn6kpcc4zszp50q7sj42mxz5um8mwdsa
Current NFT ID #425487 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
425487
Accession (UniProt):
B2V536
Name::
Protein adenylyltransferase SelO
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V536 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V536|SELO_CLOBA Protein adenylyltransferase SelO OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=selO PE=3 SV=1 MKNKEIIINNYLNLENNYIKLPKKLFSEQNPSEVPSTNLVVFNESLASDLGLSEEFLQSDDGINFLSGNKILEDTIPIAQAYAGHQFGHFTMLGDGRAILLGELKSQNGERFDIQLKGSGRTPYSRGGDGKATLGAMLREYIISEGMHGLGIPTTRSLAVVSTGEDVIREEILKGAVLTRIAKSHIRVGTFQFISNYGTIEELKALADYTLNRHLKKAEYEGNPYIYLLNEVIKSQAKLISKWQLVGFVHGVMNTDNVTISGETIDYGPCAFMDVYDPDTVFSSIDINGRYAYGNQPKIGVWNLARFAETLLPLLDEDLESAVEIAQNSISKYSDLYNKYWYTGMRAKLGIFNEKEEDKELIQSLLTMMKRFKADYTNTFSNLTLGNLSDIDMFASKEFKMWYEVWKERLKSQNQSSEESKMLMEKSNPTIIPRNNRVEEALVAAIKDSDYSVMQSLLDVLKNPYDYSSINEYYSIVPKSTSCTYKTYCGT